Innovation Pharmaceuticals IIPIX
13F holders, Q2 2024 (June 30)2holders −1
0new positions
1sold out
$0.00avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Innovation Pharmaceuticals I (IPIX) in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holders were Able Wealth Management LLC ($67) and Kingfisher Capital LLC ($0).
- Company
- Innovation Pharmaceuticals I
- CUSIP
- 45782D100
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $143 |
All 13F filers, Q1 2024 → Q2 2024: 10,000 shares sold, net −10,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Able Wealth Management LLC | 0.00% | No change | 55,894 | $67 |
| Kingfisher Capital LLC | 0.00% | No change | 11,000 | $0 |
"% of holder's portfolio" is IPIX's weight in each manager's 13F, not the share of Innovation Pharmaceuticals I the manager owns.